US2017190708A1PendingUtilityA1
Pyrazolo[1,5-a]pyrimidines for antiviral treatment
Est. expiryJun 24, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Kerim BabaogluConstantine G. BoojamraEugene J. EisenbergHon Chung HuiRichard L. MackmanJay P. ParrishMichael SangiOliver L. SaundersDustin SiegelDavid SperandioHai Yang
A61P 31/12A61P 31/14A61P 31/16A61P 11/00A61K 31/55C07D 513/04A61K 31/675C07D 495/04A61K 31/551C07D 519/00C07F 9/65616A61K 31/519A61K 31/5377C07D 487/04A61K 45/06
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides compounds of Formula I or Formula II: or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
Claims
exact text as granted — not AI-modified1 - 38 . (canceled)
39 . A compound of Formula VIIc:
or a pharmaceutically acceptable salt thereof;
wherein:
R 1 is H;
R 7 is C 1-8 alkyl;
R 8 is pyrrolidinyl or azetidinyl wherein pyrrolidinyl or azetidinyl is optionally substituted with one or more hydroxy, NH 2 , or —CN; and
Ar isJoin the waitlist — get patent alerts
Track US2017190708A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.